Market Place
Sourcing Support
All News #Library
Rare Diseases
Shire R&D chief Andy Busch jumps ship amid Takeda megamerger
09 Apr 2019 //
FIERCE BIOTECH
Supernus Pharma`s ADHD drug meets main goal in study on adolescents
21 Dec 2018 //
REUTERS
Shire to present new HELP Study Data for lanadelumab in HAE
20 Nov 2018 //
PHARMABIZ
LUM001: Mike Grey gets his drug back from Shire — along with $120M
07 Nov 2018 //
ENDPTS
EMA Recommends New medicine for Hereditary Angioedema
20 Oct 2018 //
EMA
Shire`s drug for rare swelling disorder wins European panel green light
19 Oct 2018 //
REUTERS
Shire opens $1B plant to make rare disease drugs
13 Oct 2018 //
FIERCE PHARMA
FDA approves Shire drug for rare swelling disorder
23 Aug 2018 //
REUTERS
GSK offloads rare disease gene therapies to Orchard Therapeutics
13 Apr 2018 //
FIERCE BIOTECH
Shire, Microsoft and EURODIS form rare diseases alliance
20 Feb 2018 //
PHARMA TIMES
Shire readies in-house production of rare disease drug Cinryze
24 Jan 2018 //
FIERCE PHARMA
First patient treated with Sangamo’s gene-editing tech
17 Nov 2017 //
PMLIVE
Shire: Getting smart with dellvery tech key in developing orphan drugs
05 Oct 2017 //
IN PHARMATECHNOLOGIST
Shire Expands Broad Monoclonal Antibody Research Platform, Enters License Agreement
17 Jul 2017 //
GLOBENEWSWIRE
Rare-Disease Drugmakers Join in Worries Over GOP Health Overhaul
06 Jul 2017 //
BLOOMBERG
Shire gains $2B in market cap as rare disease drug aces late-stage trial
20 May 2017 //
BIZJOURNAL
Rare disease sufferers wait two more years for life-changing treatment
18 Mar 2017 //
JEWISH NEWS
Tapping into the rare disease market
11 Mar 2017 //
BIO PHARMA DIVE
RaNA Acquires Shire’s Industry Leading Messenger RNA Platform
05 Jan 2017 //
BUSINESS WIRE
Shire offers £12bn-plus for Actelion
08 Jun 2015 //
PHARMA TIMES
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.